176
Views
20
CrossRef citations to date
0
Altmetric
Original Article

Interpreting clinical trial results of patient-perceived onset of effect in asthma: methods and results of a Delphi panel

, , , , &
Pages 1563-1571 | Accepted 23 Mar 2009, Published online: 18 May 2009

References

  • National Asthma Education and Prevention Program (NAEPP). Expert panel report III: Guidelines for the diagnosis and management of asthma. NIH Publication 2007:11-415
  • Sims JM. An overview of asthma. Dimens Crit Care Nurs 2006;25:264-8
  • Leidy NK, Mathias S, Parasuraman B, et al. Development and validation of an onset of effect questionnaire for patients with asthma. Allergy and Asthma Proc 2008;29:590-9
  • Kuna P, Kuprys I. Symbicort turbuhaler: A new concept in asthma management. Int J Clin Pract 2002;56:797-803
  • van der Woude HJ, Boorsma M, Bergqvist PB, et al. Budesonide/formoterol in a single inhaler rapidly relieves methacholine-induced moderate-to-severe bronchoconstriction. Pulm Pharmacol Ther 2004;17:89-95
  • Kaiser H, Parasuraman B, Boggs R, et al. Onset of effect of budesonide and formoterol administered via one pressurized metered-dose inhaler in patients with asthma previously treated with inhaled corticosteroids. Ann Allergy Asthma Immunol 2008;101:295-303
  • Leidy N, Patrick D, Boggs R, et al. Perceived onset of effect of budesonide and formoterol administered via one pressurized metered-dose inhaler in patients with asthma previously receiving inhaled corticosteroids. J Allergy Clin Immunol 2007;119:S246-7
  • McGlynn EA, Kosecoff J, Brook RH. Format and conduct of consensus development conferences. Multi-nation comparison. Int J Technol Assess Health Care 1990;6:450-69
  • Noonan M, Rosenwasser LJ, Martin P, et al. Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial. Drugs 2006;66:2235-54
  • Corren J, Korenblat PE, Miller CJ, et al. Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared with budesonide alone and formoterol alone in adolescents and adults with asthma. Clin Ther 2007;29:823-43
  • Rabe KF, Adachi M, Lai CK, et al. Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J Allergy Clin Immunol 2004;114:40-7
  • Lai CK, De Guia TS, Kim YY, et al. Asthma control in the Asia-Pacific region: the Asthma Insights and Reality in Asia-Pacific Study. J Allergy Clin Immunol 2003;111:263-8
  • Factors influencing patient decisions about the use of asthma controller medication. Ann Allergy Asthma Immunol 2007;98:322-8
  • Wyrwich KW, Nelson HS, Tierney WM, et al. Clinically important differences in health-related quality of life for patients with asthma: an expert consensus panel report. Ann Allergy Asthma Immunol 2003;91:148-53
  • Wyrwich KW, Tierney WM, Babu AN, et al. A comparison of clinically important differences in health-related quality of life for patients with chronic lung disease, asthma, or heart disease. Health Serv Res 2005;40:577-91
  • Armon K, Stephenson T, MacFaul R, et al. An evidence and consensus based guideline for the management of a child after a seizure. Emerg Med J 2003;20:13-20
  • Asch SM, Kerr EA, Lapuerta P, et al. A new approach for measuring quality of care for women with hypertension. Arch Intern Med 2001;161:1329-35
  • Dellinger RP, Carlet JM, Masur H, et al. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004;32:858-73
  • Meijer R, Ihnenfeldt D, Vermeulen M, et al. The use of a modified Delphi procedure for the determination of 26 prognostic factors in the sub-acute stage of stroke. Int J Rehabil Res 2003;26:265-70
  • Morris C. Development of the gross motor function classification system (1997). Dev Med Child Neurol 2008;50:5
  • Prasad SA, Main E, Dodd ME. Finding consensus on the physiotherapy management of asymptomatic infants with cystic fibrosis. Pediatr Pulmonol 2008;43:236-44

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.